Prothena Corp Public PRTA
NASDAQ PRTA
$8.54 +0.16 (+1.91%)
At close: Oct 1, 2026 · 4:00 PM EDT

Prothena Corp Public (PRTA) Depreciation & Amortization (CF) (2012 - 2026)

Updated

Prothena Corp Public (PRTA) recorded Depreciation & Amortization (CF) of $197,000 in Q2 2026, down 12.4% from $225,000 a year earlier but up 7.1% from the prior quarter.

Analysis

Prothena Corp Public (PRTA) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

On a TTM basis, Prothena Corp Public's Depreciation & Amortization (CF) came in at $828,000 as of Jun 30, 2026, down 7.5% year-over-year; for FY2025, it came in at $895,000, up 0.2% from FY2024.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of -10.0% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $893,000 in FY2024 (-3.8%), $928,000 in FY2023 (+24.7%), $744,000 in FY2022 (-33.3%) and $1.12 million in FY2021 (-26.4%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $182,000 in Q1 2022 to $280,000 in Q3 2021 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined for three consecutive quarters, with an average decline of 6.3% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 40.8% in Q4 2023, against a decline of 40.1% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $184,000 (Q1 2026), $218,000 (Q4 2025) and $229,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Prothena Corp Public 433.62 Mn -822.46 Mn - 197,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 197,000.00
Mar 31, 2026 184,000.00
Dec 31, 2025 218,000.00
Sep 30, 2025 229,000.00
Jun 30, 2025 225,000.00
Mar 31, 2025 223,000.00
Dec 31, 2024 221,000.00
Sep 30, 2024 226,000.00
Jun 30, 2024 231,000.00
Mar 31, 2024 215,000.00
Dec 31, 2023 276,000.00
Sep 30, 2023 229,000.00
Jun 30, 2023 222,000.00
Mar 31, 2023 201,000.00
Dec 31, 2022 196,000.00
Sep 30, 2022 182,000.00
Jun 30, 2022 184,000.00
Mar 31, 2022 182,000.00
Dec 31, 2021 240,000.00
Sep 30, 2021 280,000.00
API Access

Prothena Corp Public Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PRTA&period=max&api_key=YOUR_API_KEY